Cargando…
ERBB receptors in cancer: signaling from the inside
ERBB receptor tyrosine kinases are activated by ligand-induced dimerization followed by activation and transphosphorylation of their intracellular kinase domains. A recent study by Bill and colleagues demonstrates that receptor transphosphorylation can be regulated from inside the cell by members of...
Autor principal: | Arteaga, Carlos L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219176/ https://www.ncbi.nlm.nih.gov/pubmed/21457523 http://dx.doi.org/10.1186/bcr2829 |
Ejemplares similares
-
Outsmarting cancer: the power of hybrid genomic/proteomic biomarkers to predict drug response
por: Rexer, Brent N, et al.
Publicado: (2014) -
Chaperone-mediated destruction of erbB2: relevance to tyrosine kinase inhibitors
por: Gee, Julia MW
Publicado: (2002) -
An insider's view of the new diagnostic and statistical manual of North American psychiatry (DSM-5)
por: Escobar, Javier I
Publicado: (2013) -
YAP-Hippo signalling downstream of leukemia inhibitory factor receptor: implications for breast cancer
por: Hergovich, Alexander
Publicado: (2012) -
Extreme growth factor signalling can promote oestrogen receptor-α loss: therapeutic implications in breast cancer
por: Gee, Julia MW, et al.
Publicado: (2004)